Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mathurin

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
BMC Medicine|February 17, 2021
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseasesNurdan Guldiken, Josepmaria Argemi, Berivan Gurbuz, et al.
Gastroenterology|January 28, 2014
Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNAHenry L Y Chan, Chi Kuen Chan, Aric Josun Hui, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Plos One|March 17, 2016
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver DiseasesBertrand Nalpas, Philippe Ichaï, Laure Jamot, et al.
Obesity (Silver Spring, Md.)|November 21, 2023
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort studyVioleta Raverdy, Estelle Chatelain, Guillaume Lasailly, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 30, 2008
NOD2: a potential target for regulating liver injuryMathilde Body-Malapel, Sébastien Dharancy, Dominique Berrebi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisJessica A Musto, Jens Eickhoff, Meritxell Ventura-Cots, et al.
JAMA|May 9, 2023
Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical TrialAlexandre Louvet, Julien Labreuche, Thong Dao, et al.
Journal of Hepatology|June 15, 2021
Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitisMohamed Bou Saleh, Alexandre Louvet, Line Carolle Ntandja-Wandji, et al.
JHEP Reports : Innovation in Hepatology|August 5, 2024
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtideSelma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, et al.
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
BMC Medicine|February 17, 2021
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseasesNurdan Guldiken, Josepmaria Argemi, Berivan Gurbuz, et al.
Gastroenterology|January 28, 2014
Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNAHenry L Y Chan, Chi Kuen Chan, Aric Josun Hui, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Plos One|March 17, 2016
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver DiseasesBertrand Nalpas, Philippe Ichaï, Laure Jamot, et al.
Obesity (Silver Spring, Md.)|November 21, 2023
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort studyVioleta Raverdy, Estelle Chatelain, Guillaume Lasailly, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 30, 2008
NOD2: a potential target for regulating liver injuryMathilde Body-Malapel, Sébastien Dharancy, Dominique Berrebi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2021
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisJessica A Musto, Jens Eickhoff, Meritxell Ventura-Cots, et al.
JAMA|May 9, 2023
Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical TrialAlexandre Louvet, Julien Labreuche, Thong Dao, et al.
Journal of Hepatology|June 15, 2021
Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitisMohamed Bou Saleh, Alexandre Louvet, Line Carolle Ntandja-Wandji, et al.
JHEP Reports : Innovation in Hepatology|August 5, 2024
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtideSelma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, et al.
Pageof 29